BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8598609)

  • 1. Cost-effectiveness of hepatitis B virus immunization.
    Watters JK; Kral AH
    JAMA; 1996 Mar; 275(12):907-8. PubMed ID: 8598609
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effectiveness of hepatitis B virus immunization.
    Sharfstein J; Wise P
    JAMA; 1996 Mar; 275(12):908; author reply 909. PubMed ID: 8598611
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-effectiveness of hepatitis B virus immunization.
    Everett WD
    JAMA; 1996 Mar; 275(12):908; author reply 909. PubMed ID: 8598610
    [No Abstract]   [Full Text] [Related]  

  • 4. Cost-effectiveness of hepatitis B virus immunization.
    Edmunds WJ; Medley GF; Nokes DJ
    JAMA; 1996 Mar; 275(12):907; author reply 909. PubMed ID: 8598608
    [No Abstract]   [Full Text] [Related]  

  • 5. Using gross national product to calculate acceptable immunisation costs: deploying cost-effectiveness calculations in reverse.
    Tyagi V; Singh SK; Sawhney A; Taneja V; Puliyel JM
    Pharmacoeconomics; 2003; 21(7):497-9. PubMed ID: 12696989
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations.
    Margolis HS; Coleman PJ; Brown RE; Mast EE; Sheingold SH; Arevalo JA
    JAMA; 1995 Oct; 274(15):1201-8. PubMed ID: 7563509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the best hepatitis B vaccination strategy for South Africa?
    Karim SS
    S Afr Med J; 1998 Jun; 88(6):693-4. PubMed ID: 9687844
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost-effectiveness of hepatitis B vaccination of prison inmates.
    Pisu M; Meltzer MI; Lyerla R
    Vaccine; 2002 Dec; 21(3-4):312-21. PubMed ID: 12450707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JCVI response on hepatitis B vaccination.
    Joint Committee on Vaccination and Immunisation
    Lancet; 2012 Mar; 379(9818):803. PubMed ID: 22386032
    [No Abstract]   [Full Text] [Related]  

  • 10. An economic evaluation of universal vaccination against hepatitis B virus.
    Fenn P; Gray A; McGuire A
    J Infect; 1996 May; 32(3):197-204. PubMed ID: 8793708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost effectiveness of hepatitis A/B versus hepatitis B vaccination for US prison inmates.
    Jacobs RJ; Rosenthal P; Meyerhoff AS
    Vaccine; 2004 Mar; 22(9-10):1241-8. PubMed ID: 15003653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost effectiveness of hepatitis immunization for US college students.
    Jacobs RJ; Saab S; Meyerhoff AS
    J Am Coll Health; 2003 May; 51(6):227-36. PubMed ID: 14510025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-benefit analysis of the Polish hepatitis B prevention programme.
    WiewiĆ³ra-Pilecka D
    Vaccine; 2000 Feb; 18 Suppl 1():S52-4. PubMed ID: 10683548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic evaluation of a 2-dose hepatitis B vaccination regimen for adolescents.
    Levaux HP; Schonfeld WH; Pellissier JM; Cassidy WM; Sheriff SK; Fitzsimon C
    Pediatrics; 2001 Aug; 108(2):317-25. PubMed ID: 11483794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chinese strategies for hepatitis B virus markers screening in hepatitis B vaccination based on cost-effectiveness analysis].
    Zhang SX
    Zhonghua Yu Fang Yi Xue Za Zhi; 1992 May; 26(3):154-8. PubMed ID: 1395956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cost-benefit analysis of vaccinal prevention of hepatitis B policy].
    Kerleau M; Flori YA; Nalpas B; LanoƩ JL; Berthelot P; Fardeau-Gautier M
    Rev Epidemiol Sante Publique; 1995; 43(1):48-60. PubMed ID: 7892516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An economic evaluation of universal infant vaccination strategies against hepatitis B in Thailand: an analytic decision approach to cost-effectiveness.
    Vimolket T; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2005 May; 36(3):693-9. PubMed ID: 16124440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of hepatitis B serology testing before hepatitis B vaccination in the Akha tribal children in northeastern Thailand.
    Custodio H; Mirza A; Salahuddin A; Ferguson K; Rathore M
    Pediatr Infect Dis J; 2011 Aug; 30(8):725. PubMed ID: 21750450
    [No Abstract]   [Full Text] [Related]  

  • 19. [Introduction of general hepatitis B vaccination in Switzerland].
    Zimmermann H; Vaudaux B; Kammerlander R
    Soz Praventivmed; 1998; 43 Suppl 1():S65-8, S138-42. PubMed ID: 9833270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost-effectiveness of introducing hepatitis B vaccine into infant immunization services in Mozambique.
    Griffiths UK; Hutton G; Das Dores Pascoal E
    Health Policy Plan; 2005 Jan; 20(1):50-9. PubMed ID: 15689430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.